IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma

Clinical trial NCT00089427 · COMPLETED

Trial details

NCT number: NCT00089427
Sponsor: INSYS Therapeutics Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Multiforme Anaplastic Astrocytoma Oligoastrocytoma

Start date: 2004-07-01
Primary completion: 2007-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.